As has been shared by a new study, published in the February 7 edition of the journal Nature Medicine , the drug, preventing the synthesis of hormone serotonin, can contribute to treating osteoporosis, a common bone-thinning disease.

This entry was posted on Tuesday, February 9th, 2010 at 8:12 am and is filed under Medicine. You can follow any responses to this entry through the RSS 2.0 feed. You can skip to the end and leave a response. Pinging is currently not allowed.